Safety/Tolerability, PK and Efficacy of IMB071703 Injection in Patients With Advanced Solid Tumors

Conditions: Recurrent or Metastatic, Advanced Solid Tumors Interventions: Drug: IMB071703 injection Sponsors: Beijng Immunoah Pharma Tech Co., Ltd. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials